Meningeal and cortical grey matter pathology in multiple sclerosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Anderson DW, Ellenberg JH, Leventhal CM, Reingold SC, Rodriguez M, Silberberg DH: Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol. 1992, 31 (3): 333-336. 10.1002/ana.410310317.
Charcot JM: Lecture VI. Disseminated Sclerosis. Pathological Anatomy. Lectures on the Diseases of the Nervous System. 1887, London: The New Sydenham Society, 157-181.
Sobel RA, Moore GRW: Demyelinating diseases. Greenfield's Neuropathology. Volume 2, 8th edition. Edited by: Love S, Louis DN, Ellison DW. 2008, Oxford University Press, 1513-1608.
Peterson JW, Bo L, Mork S, Chang A, Trapp BD: Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001, 50 (3): 389-400. 10.1002/ana.1123.
Brownell B, Hughes JT: The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1962, 25: 315-320. 10.1136/jnnp.25.4.315.
Lumsden CE: The neuropathology of multiple sclerosis. Multiple sclerosis and other demyelinating diseases. Volume 9. Edited by: Vinken PJ, Bruyn GW. Amsterdam. 1970, North Holland
Amato MP, Bartolozzi ML, Zipoli V, Portaccio E, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N: Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology. 2004, 63 (1): 89-93.
Barkhof F: The clinico-radiological paradox in multiple sclerosis revisited. Current opinion in neurology. 2002, 15 (3): 239-245. 10.1097/00019052-200206000-00003.
Lazeron RH, Langdon DW, Filippi M, van Waesberghe JH, Stevenson VL, Boringa JB, Origgi D, Thompson AJ, Falautano M, Polman CH, et al: Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR. Mult Scler. 2000, 6 (4): 280-285.
Moriarty DM, Blackshaw AJ, Talbot PR, Griffiths HL, Snowden JS, Hillier VF, Capener S, Laitt RD, Jackson A: Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images. AJNR Am J Neuroradiol. 1999, 20 (10): 1956-1962.
Rao SM, Leo GJ, Bernardin L, Unverzagt F: Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991, 41 (5): 685-691.
Rovaris M, Filippi M, Minicucci L, Iannucci G, Santuccio G, Possa F, Comi G: Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol. 2000, 21 (2): 402-408.
Sokic DV, Stojsavljevic N, Drulovic J, Dujmovic I, Mesaros S, Ercegovac M, Peric V, Dragutinovic G, Levic Z: Seizures in multiple sclerosis. Epilepsia. 2001, 42 (1): 72-79.
Spatt J, Chaix R, Mamoli B: Epileptic and non-epileptic seizures in multiple sclerosis. J Neurol. 2001, 248 (1): 2-9. 10.1007/s004150170262.
Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ: Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler. 2003, 9 (4): 323-331. 10.1191/1352458503ms917oa.
Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ: Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003, 62 (7): 723-732.
Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T: Cortical lesions in multiple sclerosis. Brain. 1999, 122 (Pt 1): 17-26.
Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H: Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005, 128 (Pt 11): 2705-2712.
Richert ND, Ostuni JL, Bash CN, Duyn JH, McFarland HF, Frank JA: Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b. AJNR Am J Neuroradiol. 1998, 19 (9): 1705-1713.
Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM: Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology. 2006, 67 (6): 960-967. 10.1212/01.wnl.0000237551.26858.39.
Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Wolfgang B, Parisi JE, Scheithauer BW, Giannini C, et al: Inflammatory Cortical Demyelination in Early Multiple Sclerosis. N Engl J Med. 2011, 365 (23): 2188-2197. 10.1056/NEJMoa1100648.
Duvernoy HM, Risold PY: The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev. 2007, 56 (1): 119-147. 10.1016/j.brainresrev.2007.06.002.
Geurts JJ, Bo L, Roosendaal SD, Hazes T, Daniels R, Barkhof F, Witter MP, Huitinga I, van der Valk P: Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol. 2007, 66 (9): 819-827. 10.1097/nen.0b013e3181461f54.
Huitinga I, De Groot CJ, Van der Valk P, Kamphorst W, Tilders FJ, Swaab DF: Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol. 2001, 60 (12): 1208-1218.
Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, Stadelmann C, Bruck W, Rauschka H, Schmidbauer M, et al: Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol. 2007, 17 (1): 38-44. 10.1111/j.1750-3639.2006.00041.x.
Papadopoulos D, Dukes S, Patel R, Nicholas R, Vora A, Reynolds R: Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol. 2009, 19 (2): 238-253. 10.1111/j.1750-3639.2008.00177.x.
Popescu BF, Bunyan RF, Parisi JE, Ransohoff RM, Lucchinetti CF: A case of multiple sclerosis presenting with inflammatory cortical demyelination. Neurology. 2011, 76 (20): 1705-1710. 10.1212/WNL.0b013e31821a44f1.
Bunyan RF, Popescu BF, Carter JL, Caselli RJ, Parisi JE, Lucchinetti CF: Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination. Arch Neurol. 2011, 68 (4): 525-528. 10.1001/archneurol.2011.50.
Gilmore CP, Donaldson I, Bo L, Owens T, Lowe J, Evangelou N: Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry. 2009, 80 (2): 182-187. 10.1136/jnnp.2008.148767.
Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P: Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol. 2005, 64 (12): 1101-1107. 10.1097/01.jnen.0000190067.20935.42.
Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F: Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007, 130 (Pt 4): 1089-1104.
Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F: Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14 (2): 164-174. 10.1111/j.1750-3639.2004.tb00049.x.
Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, et al: Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med. 2007, 204 (12): 2899-2912. 10.1084/jem.20071030.
Torkildsen O, Stansberg C, Angelskar SM, Kooi EJ, Geurts JJ, van der Valk P, Myhr KM, Steen VM, Bo L: Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol. 2010, 20 (4): 720-729.
Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, Roughan JE, Almendinger SE, Blewett MM, Bruck W, et al: Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain. 2009, 132 (Pt 12): 3318-3328.
Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, Serafini B, Aloisi F, Roncaroli F, Magliozzi R, et al: Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain. 2011, 134 (Pt 9): 2755-2771.
Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM: Thalamic neurodegeneration in multiple sclerosis. Ann Neurol. 2002, 52 (5): 650-653. 10.1002/ana.10326.
Simon JH, Kinkel RP, Jacobs L, Bub L, Simonian N: A Wallerian degeneration pattern in patients at risk for MS. Neurology. 2000, 54 (5): 1155-1160.
Bo L, Geurts JJ, van der Valk P, Polman C, Barkhof F: Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol. 2007, 64 (1): 76-80. 10.1001/archneur.64.1.76.
Vrenken H, Pouwels PJ, Geurts JJ, Knol DL, Polman CH, Barkhof F, Castelijns JA: Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging. 2006, 23 (5): 628-636. 10.1002/jmri.20564.
Calabrese M, Gallo P: Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler. 2009, 15 (8): 933-941. 10.1177/1352458509106510.
De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, et al: Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology. 2003, 60 (7): 1157-1162.
Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, Morra A, Rinaldi L, Romualdi C, Perini P, et al: Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol. 2007, 64 (10): 1416-1422. 10.1001/archneur.64.10.1416.
Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, et al: Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol. 2009, 66 (9): 1144-1150. 10.1001/archneurol.2009.174.
Calabrese M, Grossi P, Favaretto A, Romualdi C, Atzori M, Rinaldi F, Perini P, Saladini M, Gallo P: Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. J Neurol Neurosurg Psychiatry. 2011
Sharma R, Narayana PA, Wolinsky JS: Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler. 2001, 7 (4): 221-226.
Popescu BF, Bunyan RF, Parisi JE, Ransohoff RM, Lucchinetti C: A Case of Multiple Sclerosis Presenting with Inflammatory Cortical Demyelination. Neurology. 2011, 76 (20): 1705-10. 10.1212/WNL.0b013e31821a44f1.
Merkler D, Ernsting T, Kerschensteiner M, Bruck W, Stadelmann C: A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain. 2006, 129 (Pt 8): 1972-1983.
Albert M, Antel J, Bruck W, Stadelmann C: Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 2007, 17 (2): 129-138. 10.1111/j.1750-3639.2006.00043.x.
Brown DA, Sawchenko PE: Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol. 2007, 502 (2): 236-260. 10.1002/cne.21307.
Lassmann H, Wisniewski HM: Chronic relapsing EAE. Time course of neurological symptoms and pathology. Acta Neuropathol. 1978, 43 (1-2): 35-42. 10.1007/BF00684996.
Weller RO, Engelhardt B, Phillips MJ: Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol. 1996, 6 (3): 275-288. 10.1111/j.1750-3639.1996.tb00855.x.
Calabrese M, Filippi M, Gallo P: Cortical lesions in multiple sclerosis. Nature reviews Neurology. 2010, 6 (8): 438-444. 10.1038/nrneurol.2010.93.
Filippi M, Rocca MA: Novel MRI approaches to assess patients with multiple sclerosis. Current opinion in neurology. 2010, 23 (3): 212-217. 10.1097/WCO.0b013e32833787b0.
Geurts JJ, Barkhof F: Grey matter pathology in multiple sclerosis. Lancet Neurol. 2008, 7 (9): 841-851. 10.1016/S1474-4422(08)70191-1.
Pirko I, Lucchinetti CF, Sriram S, Bakshi R: Gray matter involvement in multiple sclerosis. Neurology. 2007, 68 (9): 634-642. 10.1212/01.wnl.0000250267.85698.7a.